17.12.2012 Views

crc press - E-Lib FK UWKS

crc press - E-Lib FK UWKS

crc press - E-Lib FK UWKS

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

102 Cell-Penetrating Peptides: Processes and Applications<br />

A similar strategy has been used to develop a short amphipathic peptide carrier for<br />

protein delivery. This peptide carrier (chariot) contains three domains: a hydrophobic<br />

tryptophan-rich motif, an NLS domain derived from the SV40 large T antigen, and<br />

a spacer domain which improves flexibility and integrity of the hydrophobic and the<br />

hydrophilic domains. Chariot is able to efficiently deliver a variety of peptides and<br />

proteins into several cell lines in a fully biologically active form, without the need<br />

for prior chemical covalent coupling or denaturation steps. 52<br />

5.4 UTILIZATION OF THE NLS PATHWAY FOR NUCLEAR IMPORT<br />

OF GENE DELIVERY VECTORS<br />

5.4.1 CHALLENGES IN GENE DELIVERY<br />

In the past 5 years the potential hazards of viral vectors as well as their immunogenicity<br />

have led research in the field of gene therapy to focus at least in part on<br />

the design of new tools and methods for gene delivery. In this respect, the major<br />

challenge resides in the design of nonviral vectors that can compensate for the poor<br />

permeability of the cell membrane to nucleic acids and improve intracellular trafficking<br />

and nuclear delivery of genes into target cells with minimal toxicity. 5,9,76-78<br />

Nonviral systems present several advantages over viral systems, in that they are<br />

simple to use, easily produced, do not induce specific immune responses, and are<br />

less cytotoxic. Cell-penetrating peptides constitute an interesting subclass among<br />

nonviral gene delivery systems. The challenge in peptide-based gene delivery systems<br />

is to define the ideal formulation that satisfies most of the major requirements:<br />

(1) reversible binding to cargo or DNA, (2) cellular or tissue specificity essential<br />

for in vivo gene delivery, (3) membrane fusogenic or disruptive activities, and (4)<br />

ability to promote nuclear translocation of plasmids (Figure 5.2).<br />

One of the major issues in gene therapy is the dependency of delivery systems<br />

on the mitotic activity of cells, illustrated by lack of efficient delivery into nondividing<br />

cells. This is primarily due to the inability of most nonviral gene delivery<br />

systems to translocate plasmids into the nucleus of nondividing cells. Several modifications<br />

of plasmid DNA have been proposed to improve their interaction with the<br />

nuclear import machinery, including additional cloning of specific DNA sequences<br />

recognized by transcription factors, the attachment of glycosylated moieties, or of<br />

synthetic peptides containing a nuclear localization signal. 79,80 Alternatively, NLSs<br />

have been incorporated into nonviral gene delivery systems and either noncovalently<br />

or covalently linked to the cargo or the DNA. Except for a few examples, incorporation<br />

of an NLS significantly increases the efficiency of transfection. However, in<br />

contrast to their effect on proteins, NLSs do not appear to improve nuclear targeting<br />

of DNA; significantly in most cases, NLS simply improves formation of DNA and<br />

peptide complexes through electrostatic interactions. 8,9<br />

5.4.2 NONCOVALENT INCORPORATION OF NUCLEAR LOCALIZATION SEQUENCES<br />

Noncovalent attachment of the NLS can be achieved by taking advantage of the<br />

cationic residues within the NLS or by fusion or covalent binding of the NLS to a

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!